Resources[1]

[1] Giving you the power of knowing.

CHR for Society volunteer with Nishkam SWAT providing meals and drinks to homeless people across London

In the UK, thousands of people have very little or nothing to wear; yet, clothing...

CHR Welcomes New Finance & Operations Director John Arthur

We are delighted to announce that John Arthur has been appointed our new Finance &...

CHR for Nature Launch

Earlier this year, we at CHR launched our Corporate Social Responsibility framework with the goal...

How CHR is maintaining & developing it’s social culture under COVID

CHR has always had a flexible work policy, with several of our consultants working remotely...

MPhil in Therapeutics Sciences at the University of Cambridge

Before the lockdown, a senior team from CHR, comprising of Matteo Perucchini (Partner), Chris Stevenson...

CHR Announces Appointment of New CEO Chris Stevenson

We are thrilled to announce the appointment of Chris Stevenson as chief executive officer. Chris...

CHR Wins Prestigious Queen’s Award for Enterprise 2020

We are honoured and thrilled to announce that we have received the 2020 Queen’s Award...

Joining CHR from home quarantine

As CHR continues to grow and recruit during this difficult time, one of it’s newest...

Meet the Team – Virtually!

On the 2nd of April, we hosted our first virtual Meet the Team (MTT) event....

We are working from home

With the well-being of our staff in mind we have taken the difficult decision to...

Sustainability Month At Cambridge Healthcare Research – Plant Potting Day!

This June we’re highlighting all things sustainability at CHR.  Our sustainability and CHR for Society

Read article
Sustainability Month At Cambridge Healthcare Research – Plant Potting Day!

UCL Careers Event – Life Science Industry Week (Workshop)

On the 11th March, an experienced team of our consultants delivered an experiential workshop on...

Cambridge Half Marathon

On March 8th, 2020 16 members of the CHR team ran the Saucony Cambridge Half...

CHR’s Generics, Biosimilars & Hospital Team Celebrate a busy Q4!

In Q4 2019, CHR’s Generics, Biosimilars and Hospitals teams celebrated the work they have conducted...

We are MHFA Qualified

Every day, we’re all being faced with challenges. Understandably, in any business community there’s a...

Our Commitment to Care, Help, Reach

At CHR, we are committed to creating a sustainable future for ourselves, our clients and...

Joining the Fight Against COVID-19

We are living in challenging times and CHR is committed to supporting those fighting COVID-19....

No one should have no one at Christmas

Loneliness is a subjective feeling and, if persistent, can have a significant negative impact on...

‘tis the Season for Giving

With only a few days left until Christmas, CHR would like to wish happy holidays...

Christmas & New Year Celebrations at CHR & Vox.Bio

CHR are recovering from quite a party! CHR’s Operations team organised a proper party for...

Latest from Solici

Visit site

Alyftrek’s FDA Approval Marks Another Advancement in Cystic Fibrosis Treatment—But Is It a True Game Changer?

Following its FDA approval in December 2024, Vertex Pharmaceuticals is preparing to launch Alyftrek, a...
Read article

Who Funds The (Women’s Health) World? Girls.

Caveat – any reference to female/ woman, is based on the biological and physiological characteristics...
Read article

Treatment precision: will alpha-emitters change the radioligand therapy landscape in prostate and neuroendocrine cancers?

  Radioligand therapies (RLTs), in contrast to traditional treatment methods, have the potential to target...
Read article

The Copycat Market: Season of Migration to the East?

For a period, the regulated copycat market enjoyed the entry of large innovator pharma who...
Read article

Jeanne Penn joins Cambridge Healthcare Research as Vice President, US Commercial for Solici

Jeanne Penn has been appointed as Vice President, US Commercial for Solici, the strategic competitive...
Read article

Bispecifics: A breath of fresh air for th2 respiratory disease?

Current biological approaches for Th2 respiratory disease, and in particular, severe asthma, target individual cytokines...
Read article

Latest from Vox.Bio

Visit site

Vox.Bio Awarded as Top Consulting Company 2024 by MedTech Outlook

Vox.Bio has been recognised with the award “Top Medical Device Consulting Company in the UK”...
Read article

Vox.Bio Senior Research Executive, Gaia Ferracci PhD, wins EPHMRA’s 2023 Young Professional Grant

We’re thrilled to announce that Gaia Ferracci, Senior Research Executive has been announced as one...
Read article

No more box-ticking: the rise of digitalisation will finally put patients front and centre

Pharmaceutical companies increasingly claim to be ‘patient-centric’ – a ‘tick-box’ buzzword used primarily to improve...

Private: Aneesa Sajid
Read article

Looking Back To Look Forward – What can we learn from looking at failed innovation from digital leaders in big tech

We’re passionate about insights and data, and Vox.Bio we believe that looking beyond your own...

Harry Bullimore
Read article

Webinar: The role of the patient influencer in the future of healthcare

Watch the webinar in full here.   On Tuesday 25th April 2023 we were thrilled...
Read article

The future of digital health in healthcare

We’re thrilled to introduce our latest content series – Digital Health. Matt Lasmanis Chief Technology...
Read article